This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shanghai Yile Biotechnology Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Changqi Li: Innovator in Biotechnology
Introduction
Changqi Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for autoimmune diseases. His innovative work has garnered attention in the scientific community.
Latest Patents
Changqi Li holds a patent for a binding molecule that specifically targets the precursor of brain-derived neurotrophic factor (proBDNF). This binding molecule, particularly a monoclonal antibody against proBDNF, has potential applications in preventing, mitigating, or treating autoimmune diseases. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Li is currently associated with Shanghai Yile Biotechnology Co., Ltd., where he continues to push the boundaries of research and innovation. His work is characterized by a focus on developing solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Huamao Wang and Ruping Dai, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Changqi Li's contributions to biotechnology exemplify the impact of innovative thinking in addressing complex health issues. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile